Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-10T22:00:03.682Z Has data issue: false hasContentIssue false

The prevalence of obesity in children with CHD: what has changed over the past decade in Southwestern Ontario?

Published online by Cambridge University Press:  09 January 2025

Nathan Frewen
Affiliation:
Department of Paediatrics, Western University, London, Canada
Ajaya Sharma
Affiliation:
Department of Paediatrics, Western University, London, Canada
Mathushan Subasri
Affiliation:
Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada
Michael R. Miller
Affiliation:
Department of Paediatrics, Western University, London, Canada Children’s Health Research Institute, London, Canada
Gitanjali Mansukhani
Affiliation:
Department of Paediatrics, Western University, London, Canada Children’s Health Research Institute, London, Canada
Guido Filler
Affiliation:
Department of Paediatrics, Western University, London, Canada Children’s Health Research Institute, London, Canada
Kambiz Norozi*
Affiliation:
Department of Paediatrics, Western University, London, Canada Children’s Health Research Institute, London, Canada Department of Paediatric Cardiology and Intensive Care Medicine, Medical School Hannover, Hannover, Germany
*
Corresponding author: Kambiz Norozi; Email: kambiz.norozi@lhsc.on.ca
Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the prevalence of obesity and investigate any changes in body mass index in children with CHD compared to age-matched healthy controls, in Southwestern Ontario.

Methods:

The body mass index z-scores of 1259 children (aged 2–18) with CHD were compared with 2037 healthy controls. The body mass index z-scores of children who presented to our paediatric cardiology outpatient clinic from 2018 to 2021 were compared with previously collected data from 2008 to 2010. A longitudinal analysis of patients with data in both cohorts was also completed.

Results:

In total, 21.4% of patients with CHD and 26.6% of healthy controls were found to be overweight or obese (p < 0.001). The 2018–2021 cohort of CHD patients and controls had significantly higher body mass index z-scores compared to the 2008–2010 cohort (p < 0.001). Longitudinal analysis showed that body mass index z-scores significantly increased over time for CHD patients with data in both cohorts (2018–2021: M = 0.59, SD = 1.26; 2008–2010: M = −0.04, SD = 1.05; p < 0.001).

Conclusion:

The prevalence of obesity in all children, irrespective of CHD, is rising. The coexistence of obesity and CHD may pose additional cardiovascular risks and complications.

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Introduction

Childhood obesity is an escalating public health concern worldwide, significantly impacting the well-being and long-term health of affected individuals. 13 Over the past 30 years, the prevalence of obesity among children and youth in Canada has nearly tripled 1 , meaning almost 1 in 3 children aged 5–17 are overweight or obese. 2 Childhood obesity increases the risk of developing various health problems; including asthma, type-2 diabetes, heart disease, high blood pressure, sleep apnoea, low self-esteem, and depression. 1,2 These negative comorbidities are exacerbated in conditions such as CHD, where an active lifestyle can be hindered. Reference Pinto, Marino and Wernovsky4

CHD, the most common birth defect in newborns, involves abnormalities in heart structure that occur before birth, affecting approximately 1.8% of live births globally. Reference Sun, Liu, Lu, Zheng and Zhang5,Reference Wu, He and Shao6 Ventricular septal defects and atrial septal defects are the most prevalent CHDs, accounting for 30% of all cases. Reference Sun, Liu, Lu, Zheng and Zhang5 Advances in diagnostic techniques and surgical treatments have drastically improved the life expectancy of children and adolescents with CHD. Reference Wu, He and Shao6 Today, 9 out of 10 children with CHD survive to adulthood. 7 In Canada, over 80,000 Canadian children with CHDs have ongoing management in the form of follow up and medical treatment of late complications. Reference Wu, He and Shao6,7

Obesity is a modifiable risk factor for the cardiovascular health of children with CHD, potentially exacerbating cardiovascular risks and complications. Reference Pinto, Marino and Wernovsky4,Reference Shustak, McGuire, October, Phoon and Chun8 Moreover, children with CHD may be at a higher risk of developing obesity. Reference Pinto, Marino and Wernovsky4,Reference Shustak, McGuire, October, Phoon and Chun8 Many children with CHD are often restricted from participation in physical activity, either by the direction of a physician or due to personal or family beliefs about their heart condition. Reference Shustak, McGuire, October, Phoon and Chun8 Conversely, some CHD patients at risk for failure to thrive in infancy are encouraged or recommended to gain weight through excessive feeding, which can affect long-term eating patterns. Reference Pinto, Marino and Wernovsky4,Reference Shustak, McGuire, October, Phoon and Chun8

A previous study done in our catchment area of Southwestern Ontario in 2013 examined overweight and obesity rates between children with CHD and healthy controls. Reference Welisch, Rauch, Seabrook, Filler and Norozi10 The study found no significant differences between groups; however, both groups had an overall high prevalence at 18.2% and 20.8%, respectively. Reference Welisch, Rauch, Seabrook, Filler and Norozi10 Considering the additional cardiovascular risk that obesity imposes on CHD patients, the present study aimed to assess changes in the prevalence of overweight/obesity over the past decade.

The aims of the current study were to (1) investigate the prevalence of overweight and obesity rates in children with CHD in Southwestern Ontario compared to regional age-matched controls, (2) compare BMI z-scores of the current CHD and control cohorts to those from 10 years ago, and (3) conduct a longitudinal analysis of CHD patients with follow up data to investigate changes in body mass index z-scores over the last decade.

Materials and methods

Data collection

This retrospective cross-sectional and longitudinal study was approved by the institutional review board at Western University, London, Canada (HSREB #123396). We reviewed the charts of all patients aged 2 to 18 years old who presented to our Paediatric Cardiology Outpatient Clinic from January 2018 to March 2021. A total of 6131 patient charts were reviewed and only those with complete data (weight, height, age, sex, and diagnosis) were used for the analysis. The anthropometric data at the most recent visit were used for patients with more than one visit during this period. Patients with confirmed CHD formed the CHD group and those who were referred to the cardiology clinic for evaluation but found to have no heart disease formed the healthy control group.

The CHD cohort was further divided into two groups: operated and non-operated. Congruent with our previous study, Reference Welisch, Rauch, Seabrook, Filler and Norozi10 and based on a study by Perloff et al., Reference Perloff and Child11 the operated group was further divided into three subgroups: curative, reparative, and palliative. The non-operated group was also divided into three subgroups: valvar disease, shunt lesions, and miscellaneous (Table 1).

Table 1. Categories of patients with CHD; operated patients are classified according to Perloff et al. Reference Perloff and Child11

ASD = atrial septal defect; AVSD = atrioventricular septal defect; CHD = congenital heart defect; PDA = patent ductus arteriosus; TAC = truncus arteriosus communis; TGA = transposition of the great arteries; VSD = ventricular septal defect.

A registered nurse measured standing height using a Harpenden stadiometer and body weight on a calibrated digital scale. Body mass index was calculated from height and weight data and plotted on the Centers for Disease Control and Prevention body mass index curves to determine age- and sex-appropriate percentiles and z-scores. Based on a study by Hedley et al., Reference Hedley12 and in line with our previous study, Reference Welisch, Rauch, Seabrook, Filler and Norozi10 body mass index was categorised as underweight (< 5th percentile [z-score < -1.2]), normal weight (5th–85th percentiles [z-score -1.2 – 1.2]), overweight (85th–95th percentiles [z-score 1.2 – 1.7]), and obese (> 95th percentile [z-score > 1.7]).

Exclusion criteria included patients with genetic diseases and other comorbidities; for example, Down’s syndrome, Duchenne’s muscular dystrophy, Marfan syndrome, and any malignancy or tumour that could affect body habitus (as the sequelae of treatment), and those who required a tracheostomy for ventilation or a gastrostomy tube for feeding.

Analysis and statistics

Continuous variables were summarised with means and standard deviations and comparisons between groups were examined using independent or dependent t-tests, as appropriate. Categorical variables were summarised with frequencies and percentages, and comparisons between groups were examined using chi-square tests or Fisher’s exact tests, when appropriate. Logistic regression models were used to examine predictors of overweight/obese status. All analyses were conducted using SPSS v29 (IBM Corporation, Armonk, NY, USA), and p-values<0.05 were considered statistically significant.

Results

The CHD group consisted of 1259 children and the control group included 2037. There was no significant difference in sex between groups (p = 0.66). The control group was slightly older than the CHD patients on average (9.6 versus 9.1 years, Table 2), but this was combatted through the use of age-independent z-scores.

Table 2. Study cohort characteristics

CHD = congenital heart defect; SD = standard deviation.

Significantly fewer CHD patients were obese compared to controls (14.2% vs. 19.5%, p < 0.001, Table 2), and significantly more CHD patients were normal body mass index compared to controls (72.1% vs. 68.3%, p = 0.02). However, there were no significant differences between the groups in terms of overweight or underweight status. Figure 1 illustrates the prevalence of overweight and obesity in the control group and the subgroups of CHD patients.

Figure 1. Prevalence of overweight/obesity. A: healthy control group; B: CHD patients after curative surgery; C: CHD patients after reparative surgery; D: CHD patients after palliative surgery; E: CHD non-operated patients with shunt lesions; F: CHD non-operated patients with valvar disease G: CHD non-operated patients with miscellaneous lesion.

Table 3 shows the distribution of the weight categories within each CHD subgroup. More patients were in the non-operated group than in the operated group (865 and 394, respectively). The prevalence of overweight or obesity in each subgroup was similar (data not shown).

Table 3. CHD subgroups and their distribution into weight categories

CHD = congenital heart disease.

The body mass index z-scores of overweight or obese patients were plotted against age in controls and CHD patients separately (Figs 2 and 3). The overall distribution of the body mass index z-scores within the different age groups was comparable, except for the age at which body mass index peaked. In the control group, this occurred between ages of 15 to 17 years, and in the CHD group between ages 5 to 7 years.

Figure 2. Body mass index z-score of overweight/obese control group children plotted against age. Median with 25th and 75th percentile.

Figure 3. Body mass index z-score of overweight/obese children with CHDs plotted against age. Median with 25th and 75th percentile.

Age significantly predicted overweight/obese status both for control patients (OR = 1.03, 95% CI = 1.01-1.06, p = 0.002) and for CHD patients (OR = 1.04, 95% CI = 1.01-1.07, p = 0.007), with older age increasing the risk of overweight/obesity. Male sex significantly predicted overweight/obese status for control patients (OR = 1.28, 95% CI = 1.04-1.56, p = 0.02) but was not significant for CHD patients (p = 0.28).

The 2018–2021 cohort of CHD patients had significantly higher body mass index z-scores (M = 0.36, SD = 1.46) than the 2008–2010 cohort of CHD patients (M = 0.10, SD = 1.18; p < 0.001). The 2018–2021 cohort of controls also had significantly higher body mass index z-scores (M = 0.67, SD = 1.76) compared to the 2008–2010 cohort of controls (M = 0.29, SD = 1.15; p < 0.001). For CHD patients with follow up data in both cohorts (n = 133), body mass index z-scores significantly increased over time (2018–2021: M = 0.59, SD = 1.26; 2008-2010: M = -0.04, SD = 1.05; p < 0.001).

Discussion

Childhood obesity is a growing public health concern worldwide, with one-third of North American children being overweight or obese. Reference Leung, Wong and Hon13,Reference Gurnani, Birken and Hamilton14,Reference Phelps, Singleton and Zhou15 Once established, childhood obesity is difficult to treat, and most strategies of lifestyle change lead to a rapid re-accumulation of weight once these efforts are stopped. Reference Leung, Wong and Hon13

While the Canadian average prevalence of excess weight in children and youth is 28.9%, regional differences are observed. In Ontario, 25.6% of children are overweight or obese. Reference Rao, Kropac, Do, Roberts and Jayaraman16 Our findings confirm the high rates of overweight and obesity in healthy children as well as in those with CHD (Fig 1). The CHD group consisted of 21.4% of children who were overweight/obese, and this number was 26.6% in the healthy control group; part of this difference was due to an increased number of children with obesity in the control group (19.5% vs. 14.2%, p < 0.001), with a comparable number of overweight children between groups (7.1% for both groups). According to data collected from 2017 to 2020 by the U.S. Centers for Disease Control and Prevention, childhood obesity rates were 19.7% for children and adolescents aged 2 to 19 years. 17 These data are similar to our control group (19.5%) and slightly higher than that of our CHD group (14.2%).

Age and male sex predicted overweight/obese status in the control group, but only age significantly predicted overweight/obese status in the CHD group. These findings are different from Chen et al. Reference Chen, Wang, Lue, Hua, Chang and Wu18 and Shustak et al. Reference Shustak, McGuire, October, Phoon and Chun8 who found that male sex significantly predicted overweight/obese status in CHD children, but in accordance with other publications. Reference Pinto, Marino and Wernovsky4,Reference Pasquali, Marino and Pudusseri19

Our study observed a shifting of body mass index z-scores over the last decade, such that both CHD children and healthy controls increased their body mass index z-scores overall. This remains true for CHD children with follow up data between both cohorts (Figs 25). Our data are similar to the findings of Tamayo et al. Reference Tamayo, Manlhiot, Patterson, Lalani and McCrindle20 who found that CHD patients had a trend of becoming more overweight/obese over time, similar to that of the general population. They also found that children with transposition of the great arteries had significantly higher average weights compared to other CHD groups. However, our results did not show any significant differences between the subgroups of CHD patients in terms of overweight/obesity status. Reference Shustak, McGuire, October, Phoon and Chun8 Many patients lead sedentary lifestyles after cardiac repair and demonstrate poor activity levels, which may increase the risk of obesity and other comorbidities. Reference Pinto, Marino and Wernovsky4,Reference Shustak, McGuire, October, Phoon and Chun8

Figure 4. (2008-2010 cohort). Body mass index z-score of overweight/obese control group children plotted against age. Median with 25th and 75th percentile.

Figure 5. (2008-2010 cohort). Body mass index z-score of overweight/obese patients with CHDs plotted against age. Median with 25th and 75th percentile.

Steele et al. Reference Steele, Preminger and Erenberg21 identified a critical period of 6–10 years of age where CHD patients had an increased risk of becoming overweight or obese. Our study showed a similar peak, between the ages of 5 and 7 years (Fig 3), where body mass index z-scores seemed to trend upwards. A similar spike was observed in our previous study, Reference Welisch, Rauch, Seabrook, Filler and Norozi10 but later in childhood, between the ages of 7 and 11 years (Fig 5). This may suggest that CHD children are getting overweight/obese at an earlier age than previously found. There is also a difference in body mass index peaks between CHD and control group children, whereas the control group had a peak between the ages of 15 and 17 years. We cannot offer an explanation for this finding and do not know whether there is any clinical relevance to it.

A study by Nadar et al. Reference Nader, O’Brien and Houts22 indicated that pre-school-age children who were overweight or obese (body mass index > 85th percentile) were five times as likely to be overweight/obese later in childhood, compared to those children whose body mass index was below the 85th percentile in pre-school. Reference Nader, O’Brien and Houts22

A study by Pinto et al. Reference Pinto, Marino and Wernovsky4 found that over 25% of children with congenital and acquired heart disease in Philadelphia and Boston were overweight or obese. This study also highlighted that paediatric cardiologists failed to document obesity in the majority of clinic letters, which could indicate an underestimation of its severity. Reference Pinto, Marino and Wernovsky4 Similarly, a review by Shustak et al. Reference Shustak, McGuire, October, Phoon and Chun8 found rising overweight and obesity rates among children with CHD in New York, estimated at 27% overweight and 12% obese.

Obesity has been associated with adverse outcomes for children and adolescents undergoing surgery for CHD. Reference Garcia, Balakrishnan and Aggarwal23,Reference O’Byrne, Kim and Hornik24 Garcia et al. Reference Garcia, Balakrishnan and Aggarwal23 evaluated the effects of obesity on short-term outcomes of cardiac surgery in adolescents. They found that obesity was associated with adverse outcomes and increased health resource utilisation, independent of other risk factors. Reference Garcia, Balakrishnan and Aggarwal23 O’Byrne et al. Reference O’Byrne, Kim and Hornik24 looked at the effects of obesity and underweight status on the perioperative outcomes of CHD children, adolescents, and young adults undergoing cardiac operations. They found that obese and underweight body mass indexes were associated with an increased risk of adverse perioperative outcomes. Reference O’Byrne, Kim and Hornik24 In our study, cohort the prevalence of underweight in CHD children was higher than the control group; although without statistical significance (possibly due to the low numbers). We believe this difference could be based on the combination of increased energy needs due to the heart defect and challenges in food intake that contribute to underweight status in CHD children.

Promoting a healthy body weight, good nutritional habits, and regular physical activity can help prevent and manage serious and chronic cardiovascular diseases. Reference Pemberton, McCrindle and Barkin25 In our Smart Heart Pilot Study, we were able to document positive changes in anthropometry, with significant improvements to some cardiovascular and metabolic risk factors, after 12 months of remote lifestyle counselling in overweight youth with CHDs. Reference Altamirano-Diaz, Rombeek and De Jesus26

Reducing excess energy intake, especially low nutrient-dense items like sugar-sweetened beverages, and limiting daily screen time have been shown to help improve and prevent obesity in young children. Reference Pemberton, McCrindle and Barkin25 Implementing preventative measures, especially in early childhood, seems to be key for reducing overweight/obesity prevalence in children, adolescents, and young adults. Reference Steele, Preminger and Erenberg21,Reference Nader, O’Brien and Houts22 These preventative measures should also be targeted to adults and implemented in institutions like schools and daycares. Obesity trends in the paediatric population have followed those in adults, which is likely due to the increased consumption of processed and commercial foods. As such, healthy nutrition for children and adolescents will also rely on targeting nutritional campaigns and programmes to adult caregivers as they are often the gatekeepers of what food is accessible to children during their developmental years. Reference Phelps, Singleton and Zhou15 The Canadian government has recognised that curbing childhood obesity will require a multifaceted approach, including developing frameworks for nutrition at school. 27 A recent survey of 25 school representatives showed that many schools are making actionable changes with the physical environment being most supported, but the social environment could be further developed to build a community that is motivated in making healthy choices. 27 Finally, access to these interventions and resources is another barrier as children in lower socio-economic classes are disadvantaged. There are programmes available to help mitigate food insecurity and improve access to sports. For example, Nutrition North Canada works to subsidise food for isolated northern communities, and the Ontario Student Nutrition Program administers provincial grant funds to support healthy foods for schools in lower-income neighbourhoods. 28 However, more work needs to be done to ensure these and other vulnerable groups have equitable access to nutritious food and healthy activities.

There were some limitations of the present study. Our data were collected retrospectively and did not take into consideration participants’ racial/ethnicity subgroups or socio-economic background. Comorbidities such as high blood pressure and medications were not assessed, which could have an impact on body composition. It is unclear whether the area investigated is representative of the Canadian population as a whole.

In conclusion, children with CHD are not exempt from the growing obesity epidemic that is affecting children and youth across the continent. Average body mass index percentages and z-scores have been increasing over the past decade, in both healthy controls and children with CHD, leading to further cardiovascular diseases and other comorbidities. In CHD patients, obesity is associated with adverse peri- and post-operative cardiac outcomes. There seems to be a “critical period,” between the ages of 5 and 11 years, where CHD patients have an increased risk of becoming overweight and/or obese. Preventative measures like a healthy diet, regular physical activity, reducing sugar-sweetened beverage consumption, and reducing daily screen time are key for lowering the prevalence of overweight/obesity in children and adolescents. Paediatric cardiologists should reinforce the benefits of these lifestyle modifications to individual patients. Future studies should elucidate strategies for preventing the development of obesity in children with CHD; for example, establishing an exercise programme pre- and post-surgery.

Acknowledgements

None.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Competing interests

None.

References

Canada.ca. Childhood obesity. Public Health Agency of Canada, 2023. (https://www.canada.ca/en/public-health/services/childhood-obesity/childhood-obesity.html#) Accessed May 1, 2024.Google Scholar
Canada.ca. Tackling obesity in Canada: Childhood obesity and excess weight rates in Canada. 2018. (https://www.canada.ca/en/public-health/services/publications/healthy-living/obesity-excess-weight-rates-canadian-children.html#) Accessed May 1, 2024.Google Scholar
World Health Organization. Obesity and overweight. 2024. Published March 1, 2024. (https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight) Accessed May 1, 2024.Google Scholar
Pinto, NM, Marino, BS, Wernovsky, G, et al. Obesity Is a common comorbidity in children with congenital and acquired heart disease. Pediatrics 2007; 120: e1157e1164. DOI: 10.1542/peds.2007-0306.CrossRefGoogle ScholarPubMed
Sun, R, Liu, M, Lu, L, Zheng, Y, Zhang, P. Congenital heart disease: causes, diagnosis, symptoms, and treatments. Cell Biochem Biophys 2015; 72: 857860. DOI: 10.1007/s12013-015-0551-6.CrossRefGoogle ScholarPubMed
Wu, W, He, J, Shao, X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017. Medicine 2020; 99: e20593. DOI: 10.1097/MD.0000000000020593.CrossRefGoogle ScholarPubMed
Heart and Stroke Foundation of Canada. Congenital heart disease. (https://www.heartandstroke.ca/heart-disease/conditions/congenital-heart-disease) Accessed May 1, 2024.Google Scholar
Shustak, RJ, McGuire, SB, October, TW, Phoon, CKL, Chun, AJL. Prevalence of obesity among patients with congenital and acquired heart disease. Pediatr Cardiol 2012; 33: 814. DOI: 10.1007/s00246-011-0049-y.CrossRefGoogle ScholarPubMed
Andonian, C, Langer, F, Beckmann, J, et al. Overweight and obesity: an emerging problem in patients with congenital heart disease. Cardiovasc Diagn Ther 2019; 9: S360S368. DOI: 10.21037/cdt.2019.02.02.CrossRefGoogle ScholarPubMed
Welisch, E, Rauch, R, Seabrook, JA, Filler, MG, Norozi, K. Are the children and adolescents with congenital heart disease living in Southwestern Ontario really overweight and obese? Cardiol Young 2014; 24: 848853. DOI: 10.1017/S1047951113001157.CrossRefGoogle ScholarPubMed
Perloff, JK, Child, JS. Congenital Heart Disease in Adults (2nd ed.). Philadelphia: W.B. Saunders Company, 1998. ISBN: 0-7216-2998-9.Google Scholar
Hedley, AA. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847. DOI: 10.1001/jama.291.23.2847.CrossRefGoogle ScholarPubMed
Leung, AKC, Wong, AHC, Hon, KL. Childhood obesity: an updated review. CPR 2024; 20: 226. DOI: 10.2174/1573396318666220801093225.CrossRefGoogle ScholarPubMed
Gurnani, M, Birken, C, Hamilton, J. Childhood obesity. Pediatric Clinics of North America 2015; 62: 821840. DOI: 10.1016/j.pcl.2015.04.001.CrossRefGoogle ScholarPubMed
Phelps, NH, Singleton, RK, Zhou, B, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. The Lancet 2024; 403 ( 10431 ): 10271050. DOI: 10.1016/S0140-6736(23)02750-2.CrossRefGoogle Scholar
Rao, DP, Kropac, E, Do, MT, Roberts, KC, Jayaraman, GC. Childhood overweight and obesity trends in Canada. Health Promot Chronic Dis Prev Can 2016; 36: 194198. DOI: 10.24095/hpcdp.36.9.03.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Childhood obesity facts. 2022. Updated May 17, 2022. (https://www.cdc.gov/obesity/data/childhood.html) Accessed May 1, 2024.Google Scholar
Chen, C, Wang, J, Lue, H, Hua, Y, Chang, M, Wu, M. A shift from underweight to overweight and obesity in asian children and adolescents with congenital heart disease. Paediatric Perinatal Epid 2012; 26: 336343. DOI: 10.1111/j.1365-3016.2012.01293.x.CrossRefGoogle ScholarPubMed
Pasquali, SK, Marino, BS, Pudusseri, A, et al. Risk factors and comorbidities associated with obesity in children and adolescents after the arterial switch operation and Ross procedure. Am Heart J 2009; 158: 473479. DOI: 10.1016/j.ahj.2009.06.019.CrossRefGoogle ScholarPubMed
Tamayo, C, Manlhiot, C, Patterson, K, Lalani, S, McCrindle, BW. Longitudinal evaluation of the prevalence of overweight/Obesity in children with congenital heart disease. Can J Cardiol 2015; 31: 117123. DOI: 10.1016/j.cjca.2014.08.024.CrossRefGoogle ScholarPubMed
Steele, JM, Preminger, TJ, Erenberg, FG, et al. Obesity trends in children, adolescents, and young adults with congenital heart disease. Congenit Heart Dis 2019; 14: 517524. DOI: 10.1111/chd.12754.CrossRefGoogle Scholar
Nader, PR, O’Brien, M, Houts, R, et al. Identifying risk for obesity in early childhood. Pediatrics 2006; 118: e594e601. DOI: 10.1542/peds.2005-2801.CrossRefGoogle ScholarPubMed
Garcia, RU, Balakrishnan, PL, Aggarwal, S. Does obesity affect the short-term outcomes after cardiothoracic surgery in adolescents with congenital heart disease? Cardiol Young 2020; 30: 372376. DOI: 10.1017/S1047951119003329.CrossRefGoogle ScholarPubMed
O’Byrne, ML, Kim, S, Hornik, CP, et al. Effect of obesity and underweight status on perioperative outcomes of congenital heart operations in children, adolescents, and young adults: an analysis of data from the society of thoracic surgeons database. Circulation 2017; 136: 704718. DOI: 10.1161/CIRCULATIONAHA.116.026778.CrossRefGoogle Scholar
Pemberton, VL, McCrindle, BW, Barkin, S, et al. Report of the national heart, lung, and blood institute’s working group on obesity and other cardiovascular risk factors in congenital heart disease. Circulation 2010; 121: 11531159. DOI: 10.1161/CIRCULATIONAHA.109.921544.CrossRefGoogle Scholar
Altamirano-Diaz, L, Rombeek, M, De Jesus, S, et al. Remote lifestyle counseling influences cardiovascular health outcomes in youth with overweight or obesity and congenital heart disease. Front Pediatr 2017; 5: 269. DOI: 10.3389/fped.2017.00269.CrossRefGoogle ScholarPubMed
Canada.ca. Curbing childhood obesity: a federal, provincial and territorial framework for action to promote healthy weights. 2012. Updated May 23, 2012. (https://www.canada.ca/en/public-health/services/health-promotion/healthy-living/curbing-childhood-obesity-federal-provincial-territorial-framework.html#v) Accessed September 30, 2024.Google Scholar
Ontario Student Nutrition Program. Who We Are. Ontario Student Nutrition Program. (https://osnp.ca/about/who-we-are/) Accessed September 30, 2024.Google Scholar
Figure 0

Table 1. Categories of patients with CHD; operated patients are classified according to Perloff et al.11

Figure 1

Table 2. Study cohort characteristics

Figure 2

Figure 1. Prevalence of overweight/obesity. A: healthy control group; B: CHD patients after curative surgery; C: CHD patients after reparative surgery; D: CHD patients after palliative surgery; E: CHD non-operated patients with shunt lesions; F: CHD non-operated patients with valvar disease G: CHD non-operated patients with miscellaneous lesion.

Figure 3

Table 3. CHD subgroups and their distribution into weight categories

Figure 4

Figure 2. Body mass index z-score of overweight/obese control group children plotted against age. Median with 25th and 75th percentile.

Figure 5

Figure 3. Body mass index z-score of overweight/obese children with CHDs plotted against age. Median with 25th and 75th percentile.

Figure 6

Figure 4. (2008-2010 cohort). Body mass index z-score of overweight/obese control group children plotted against age. Median with 25th and 75th percentile.

Figure 7

Figure 5. (2008-2010 cohort). Body mass index z-score of overweight/obese patients with CHDs plotted against age. Median with 25th and 75th percentile.